Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah’s Witness using chemotherapy free regimen: A case report and review of literature
Chemo-free approach is a promising opportunity to treat Jehovah's witnesses with pH-positive B cell ALL as the haemoglobin and platelets remained above transfusion thresholds. However, further research is required to fully understand and implement this approach. Future clinical trials should consider including this unique patient population to better understand their needs and improve outcomes.
Authors
- Eshan Khan (ORCID: https://orcid.org/0000-0001-9502-4264)
- Muhammad Hassan Raza (ORCID: https://orcid.org/0000-0001-9857-1909)
- Salman Fazal
- Alexis M Desjarlais
Institutions
- Allegheny Health Network (US)
- Nishtar Medical College and Hospital (PK)
- Allegheny General Hospital (US)
- Drexel University (US)
Publication Details
- Journal
- Leukemia Research Reports
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.lrr.2025.100517
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00